Development of a conditionally replicating pseudorabies virus for HER-2/neu-overexpressing bladder cancer therapy

Molecular Therapy

Volumn 15, Issue 1, 2007, Pages 131-138

  Shiau, Ai Li ^a   Lin, Yu Ping ^a   Shieh, Gia Shing ^a   Su, Chih Hau ^a   Wu, Wen Luan ^a   Tsai, Yuh Shyan ^a   Cheng, Chih Wei ^a   Lai, Ming Derg ^a   Wu, Chao Liang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLYCOPROTEIN D; GLYCOPROTEIN E; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TARGETING; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; MOUTH CANCER; NONHUMAN; ONCOLYTIC VIROTHERAPY; PROGNOSIS; PROMOTER REGION; PSEUDORABIES HERPETOVIRUS; SURVIVAL TIME; TRANSCRIPTION REGULATION; VIRUS INFECTION; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HERPESVIRUS 1, SUID; MICE; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION; PROMOTER REGIONS (GENETICS); RECEPTOR, ERBB-2; SURVIVAL RATE; TRANSCRIPTION, GENETIC; URINARY BLADDER NEOPLASMS; VIRUS REPLICATION;

CRICETINAE; HERPESVIRIDAE; HUMAN HERPESVIRUS 1; SUID HERPESVIRUS 1; SUS SCROFA;

EID: 33846007302     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300001     Document Type: Article

References (38)

1. Jimenez, RE et al. (2001). Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: Prognostic significance and comparative analysis in primary and metastatic tumors. Clin Cancer Res 7: 2440-2447.
2. Kruger, S et al. (2002). HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: Prognostic implications. Int J Cancer 102: 514-518.
3. Gandour-Edwards, R et al. (2002). Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma? Cancer 95: 1009-1015.
4. Kruger, S et al. (2002). Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: Relationship with gene amplification, clinicopathological parameters and prognostic outcome. Int J Oncol 21: 981-987.
5. Yu, D and Hung, MC (2000). Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 19: 6115-6121.
6. Harris, JD, Gutierrez, AA, Hurst, HC, Sikora, K and Lemoine, NR (1994). Gene therapy for cancer using tumour-specific prodrug activation. Gene Ther 1: 170-175.
7. Enquist, LW, Husak, PJ, Banfield, BW and Smith, GA (1998). Infection and spread of alphaherpesviruses in the nervous system. Adv Virus Res 51: 237-347.
8. Hampl, H, Ben Porat, T, Ehrlicher, L, Habermehl, KO and Kaplan, AS (1984). Characterization of the envelope proteins of pseudorabies virus. J Virol 52: 583-590.
9. Wathen, MW and Wathen, LM (1984). Isolation, characterization, and physical mapping of a pseudorabies virus mutant containing antigenically altered gp50. J Virol 51: 57-62.
10. Rauh, I and Mettenleiter, TC (1991). Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. J Virol 65: 5348-5356.
11. Peeters, B, Pol, J, Gielkens, A and Moormann, R (1993). Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice. J Virol 67: 170-177.
12. Mulder, W, Pol, J, Kimman, T, Kok, G, Priem, J and Peeters, B (1996). Glycoprotein D-negative pseudorabies virus can spread transneuronally via direct neuron-to-neuron transmission in its natural host, the pig, but not after additional inactivation of gE or gI. J Virol 70: 2191-2200.
13. Mettenleiter, TC, Zsak, L, Kaplan, AS, Ben-Porat, T and Lomniczi, B (1987). Role of a structural glycoprotein of pseudorabies in virus virulence. J Virol 61: 4030-4032.
14. Mulder, WA et al. (1994). Glycoprotein gE-negative pseudorabies virus has a reduced capability to infect second- and third-order neurons of the olfactory and trigeminal routes in the porcine central nervous system. J Gen Virol 75: 3095-3106.
15. Babic, N, Klupp, B, Brack, A, Mettenleiter, TC, Ugolini, G and Flamand, A (1996). Deletion of glycoprotein gE reduces the propagation of pseudorabies virus in the nervous system of mice after intranasal inoculation. Virology 219: 279-284.
16. McGregor, S, Easterday, BC, Kaplan, AS and Ben Porat, T (1985). Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus. Am J Vet Res 46: 1494-1497.
17. Ferrari, M et al. (2000). A comparative study of pseudorabies virus (PRV) strains with defects in thymidine kinase and glycoprotein genes. J Comp Pathol 123: 152-163.
18. Mulder, WA, Priem, J, Pol, JM and Kimman, TG (1995). Role of viral proteins and concanavalin A in in vitro replication of pseudorabies virus in porcine peripheral blood mononuclear cells. J Gen Virol 76: 1433-1442.
19. Martuza, RL, Malick, A, Markert, JM, Ruffner, KL and Coen, DM (1991). Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252: 854-856.
20. Kooby, DA et al. (1999). Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207). FASEB J 13: 1325-1334.
21. Rampling, R et al. (2000). Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther 7: 859-866.
22. Markert, JM et al. (2000). Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: Results of a phase I trial. Gene Ther 7: 867-874.
23. Boldogkoi, Z, Bratincsak, A and Fodor, I (2002). Evaluation of pseudorabies virus as a gene transfer vector and an oncolytic agent for human tumor cells. Anticancer Res 22: 2153-2159.
24. Pritchett, RF, Bush, CE, Chang, TJ, Wang, JT and Zee, YC (1984). Comparison of the genomes of pseudorabies (Aujeszky's disease) virus strains by restriction endonuclease analysis. Am J Vet Res 45: 2486-2489.
25. Shiau, AL, Liu, CW, Wang, SY, Tsai, CY and Wu, C (2002). A simple selection system for construction of recombinant gD-negative pseudorabies virus as a vaccine vector. Vaccine 20: 1186-1195.
26. Slamon, DJ et al. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344: 783-792.
27. Yu, D, Suen, TC, Yan, DH, Chang, LS and Hung, MC (1990). Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products. Proc Natl Acad Sci USA 87: 4499-4503.
28. Hudson, LG, Ertl, AP and Gill, GN (1990). Structure and inducible regulation of the human c-erb B2/neu promoter. J Biol Chem 265: 4389-4393.
29. Wollmann, G, Tattersall, P and van den Pol, AN (2005). Targeting human glioblastoma cells: Comparison of nine viruses with oncolytic potential. J Virol 79: 6005-6022.
30. Shiau, AL, Liu, PS and Wu, CL (2005). Novel strategy for generation and titration of recombinant adeno-associated virus vectors. J Virol 79: 193-201.
31. Shiau, AL, Chen, YL, Liao, CY, Huang, YS and Wu, CL (2001). Prothymosin α enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by Salmonella choleraesuis. Vaccine 19: 3947-3956.
32. Lin, SC, Chang, KW, Chang, CS, Yu, SY, Chao, SY and Wong, YK (2000). Establishment and characterization of a cell line (HCDB-1) derived from a hamster buccal pouch carcinoma induced by DMBA and Taiwanese betel quid extract. Proc Natl Sci Counc Repub China B 24: 129-135.
33. Lin, YC, Peng, JM and Wang, WB (2000). The N-terminal common domain of simian virus 40 large T and small t antigens acts as a transformation suppressor of the HER-2/neu oncogene. Oncogene 19: 2704-2713.
34. Thomson, JM and Parrott, WA (1998). pMECA: A cloning plasmid with 44 unique restriction sites that allows selection of recombinants based on colony size. Biotechniques 24: 922-924.
35. Morgenstern, JP and Land, H (1990). A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res 18: 1068.
36. Yoon, HA et al. (2005). Molecular survey of latent pseudorabies virus infection in nervous tissues of slaughtered pigs by nested and real-time PCR. J Microbiol 43: 430-436.
37. Klupp, BG, Hengartner, CJ, Mettenleiter, TC and Enquist, LW (2004). Complete, annotated sequence of the pseudorabies virus genome. J Virol 78: 424-440.
38. Sambrook, J, Fritsch, EF and Maniatis, T (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: New York.